Individuals 0 11 0 11 O
aged 12 16 12 16 B-age
30 17 19 17 19 B-lower_bound
- 19 20 19 20 O
55 20 22 20 22 B-upper_bound

Those 0 5 23 28 O
who 6 9 29 32 O
are 10 13 33 36 O
currently 14 23 37 46 O
smoking 24 31 47 54 O
or 32 34 55 57 O
have 35 39 58 62 O
smoked 40 46 63 69 O
within 47 53 70 76 O
the 54 57 77 80 O
past 58 62 81 85 B-upper_bound
3 63 64 86 87 I-upper_bound
years 65 70 88 93 I-upper_bound

Those 0 5 94 99 O
who 6 9 100 103 O
have 10 14 104 108 O
had 15 18 109 112 O
a 19 20 113 114 O
recent 21 27 115 121 O
surgical 28 36 122 130 B-treatment
or 37 39 131 133 O
cosmetic 40 48 134 142 B-treatment
procedure 49 58 143 152 I-treatment
in 59 61 153 155 B-upper_bound
the 62 65 156 159 I-upper_bound
last 66 70 160 164 I-upper_bound
3 71 72 165 166 I-upper_bound
months 73 79 167 173 I-upper_bound
that 80 84 174 178 O
can 85 88 179 182 O
affect 89 95 183 189 O
facial 96 102 190 196 O
wrinkles 103 111 197 205 O
or 112 114 206 208 O
facial 115 121 209 215 O
hyperpigmentation 122 139 216 233 B-chronic_disease
, 139 140 233 234 O
such 141 145 235 239 O
as 146 148 240 242 O
botulinum 149 158 243 252 B-treatment
toxin 159 164 253 258 I-treatment
injections 165 175 259 269 I-treatment
, 175 176 269 270 O
chemical 177 185 271 279 B-treatment
peels 186 191 280 285 I-treatment
, 191 192 285 286 O
laser 193 198 287 292 B-treatment
based 199 204 293 298 I-treatment
therapies 205 214 299 308 I-treatment
to 215 217 309 311 O
the 218 221 312 315 O
face 222 226 316 320 O
, 226 227 320 321 O
or 228 230 322 324 O
face 231 235 325 329 B-treatment
lift 236 240 330 334 I-treatment
surgeries 241 250 335 344 I-treatment

Those 0 5 345 350 O
who 6 9 351 354 O
have 10 14 355 359 O
used 15 19 360 364 O
isotretinoin 20 32 365 377 B-treatment
in 33 35 378 380 O
the 36 39 381 384 O
last 40 44 385 389 B-upper_bound
6 45 46 390 391 I-upper_bound
months 47 53 392 398 I-upper_bound

Those 0 5 399 404 O
who 6 9 405 408 O
have 10 14 409 413 O
used 15 19 414 418 O
products 20 28 419 427 O
containing 29 39 428 438 O
salicylic 40 49 439 448 B-treatment
acid 50 54 449 453 I-treatment
, 54 55 453 454 O
beta 56 60 455 459 B-treatment
hydroxyl 61 69 460 468 I-treatment
acids 70 75 469 474 I-treatment
or 76 78 475 477 O
vitamins 79 87 478 486 B-treatment
A 88 89 487 488 I-treatment
, 89 90 488 489 I-treatment
C 91 92 490 491 I-treatment
, 92 93 491 492 I-treatment
or 94 96 493 495 I-treatment
E 97 98 496 497 I-treatment
in 99 101 498 500 O
the 102 105 501 504 O
last 106 110 505 509 O
14 111 113 510 512 B-upper_bound
days 114 118 513 517 I-upper_bound

Those 0 5 518 523 O
who 6 9 524 527 O
have 10 14 528 532 O
used 15 19 533 537 O
topical 20 27 538 545 B-treatment
antibiotics 28 39 546 557 I-treatment
or 40 42 558 560 O
topical 43 50 561 568 B-treatment
retinoids 51 60 569 578 I-treatment
in 61 63 579 581 O
the 64 67 582 585 O
last 68 72 586 590 B-upper_bound
30 73 75 591 593 I-upper_bound
days 76 80 594 598 I-upper_bound

Those 0 5 599 604 O
with 6 10 605 609 O
acne 11 15 610 614 O
, 15 16 614 615 O
eczema 17 23 616 622 O
, 23 24 622 623 O
seborrheic 25 35 624 634 O
dermatitis 36 46 635 645 O
, 46 47 645 646 O
rosacea 48 55 647 654 O
or 56 58 655 657 O
polycystic 59 69 658 668 B-chronic_disease
ovarian 70 77 669 676 I-chronic_disease
syndrome 78 86 677 685 I-chronic_disease

breast 0 6 686 692 O
feeding 7 14 693 700 O
women 15 20 701 706 B-gender

